-
Product Insights
BCS – Commerce Cold Storage Facility – Georgia
The BCS – Commerce Cold Storage Facility – Georgia project involves the construction of a 19,567m2 cold storage facility in Commerce, Georgia, the US. Equip yourself with the essential tools needed to make informed and profitable decisions with our BCS – Commerce Cold Storage Facility – Georgia report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BC-3425 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BC-3425 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BC-3425 in Solid Tumor Drug Details: BC-3425 is under development for...
-
Product Insights
BC-Wind Offshore Wind Farm
BC-Wind Offshore Wind Farm is an offshore wind project located in Baltic Sea, Poland. The project is owned by EDP Renovaveis SA; Engie SA and is developed by B-Wind Polska SP. Z.O.O.; C-Wind Polska SP. Z.O.O.. The project is at the permitting stage. Empower your strategies with our BC-Wind Offshore Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3...
-
Thematic Analysis
NewMedical Devices M&A Deals, Q1 2024 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q1 2024 in the Medical Devices Sector
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Tegavivint in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tegavivint in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tegavivint in Non-Small Cell Lung Cancer Drug Details: Tegavivint (BC-2059)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tegavivint in Diffuse Large B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tegavivint in Diffuse Large B-Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tegavivint in Diffuse Large B-Cell Lymphoma Drug Details: Tegavivint...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Amivantamab in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Amivantamab in Gastric Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Amivantamab in Gastric Cancer Drug Details: Amivantamab-vmjw (Rybrevant) is a low-fucose...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Amivantamab in Esophageal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Amivantamab in Esophageal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Amivantamab in Esophageal Cancer Drug Details: Amivantamab-vmjw (Rybrevant) is a low-fucose...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Amivantamab in Gastroesophageal (GE) Junction Carcinomas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Amivantamab in Gastroesophageal (GE) Junction Carcinomas report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Amivantamab in Gastroesophageal (GE) Junction Carcinomas Drug Details: Amivantamab-vmjw...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MHB-036C in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MHB-036C in Gastric Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MHB-036C in Gastric Cancer Drug Details: MHB-036C is under development for...